Insider · CIK 0001787370

Pang Phillip

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001787370

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-22	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−14.6K sh	$10.05	−$146K	250,111
2024-02-16	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−3,321 sh	$10.24	−$34K	264,679
2024-01-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+18.8K sh	$0.85	+$16.1K	206,833
2024-01-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+13.6K sh	$1.57	+$21.4K	220,409
2024-01-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+47.6K sh	$1.53	+$72.8K	268,000
2024-01-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−18.8K sh	$0.85	−$16.1K	0
2024-01-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−13.6K sh	$1.57	−$21.4K	0
2024-01-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−47.6K sh	$1.53	−$72.8K	0
2023-06-07	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	193,000
2023-06-07	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$25.95	−$130K	188,000
2023-06-07	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	47,591
2023-02-27	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−8,920 sh	$23.00	−$205K	189,400
2023-02-27	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−1,400 sh	$23.56	−$33K	188,000
2023-02-23	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−2,878 sh	$25.97	−$74.8K	198,320
2023-02-22	VIRVir Biotechnology, Inc.A Award	EVP & Chief Medical Officer	AAward	+60K sh	—	—	201,198
2023-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+70K sh	—	—	70,000
2023-02-17	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−2,802 sh	$25.29	−$70.9K	141,198
2023-01-24	VIRVir Biotechnology, Inc.A Award	EVP & Chief Medical Officer	AAward	+25.4K sh	$1.57	+$40K	169,406
2023-01-24	VIRVir Biotechnology, Inc.A Award	EVP & Chief Medical Officer	AAward	+4,594 sh	$5.17	+$23.8K	174,000
2023-01-24	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−30K sh	$30.00	−$900K	144,000
2023-01-24	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−25.4K sh	—	—	13,576
2023-01-24	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−4,594 sh	—	—	37,535
2022-07-20	VIRVir Biotechnology, Inc.A Award	EVP & Chief Medical Officer	AAward	+5,000 sh	$1.57	+$7,875	149,000
2022-07-20	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$30.00	−$150K	144,000
2022-07-20	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	38,982
2022-06-21	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−4,991 sh	$24.89	−$124K	144,000
2022-04-15	VIRVir Biotechnology, Inc.G Gift	EVP & Chief Medical Officer	GGift	−7,777 sh	—	—	148,991
2022-02-22	VIRVir Biotechnology, Inc.A Award	EVP & Chief Medical Officer	AAward	+67K sh	—	—	156,768
2022-02-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+64K sh	—	—	64,000
2022-02-17	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−3,009 sh	$31.93	−$96.1K	89,768
2022-02-16	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	97,777
2022-02-16	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$31.54	−$158K	92,777
2022-02-16	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	52,591
2022-02-02	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	97,777
2022-02-02	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$34.52	−$173K	92,777
2022-02-02	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	57,591
2022-01-19	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	97,777
2022-01-19	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−2,458 sh	$34.59	−$85K	95,319
2022-01-19	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−2,542 sh	$35.52	−$90.3K	92,777
2022-01-19	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	62,591
2022-01-05	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	97,777
2022-01-05	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−4,600 sh	$37.14	−$171K	93,177
2022-01-05	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−400 sh	$37.78	−$15.1K	92,777
2022-01-05	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	67,591
2021-12-15	VIRVir Biotechnology, Inc.M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+5,000 sh	$1.53	+$7,650	97,777
2021-12-15	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−1,716 sh	$49.41	−$84.8K	96,061
2021-12-15	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−1,050 sh	$50.60	−$53.1K	95,011
2021-12-15	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−1,034 sh	$51.30	−$53K	93,977
2021-12-15	VIRVir Biotechnology, Inc.S Sale	EVP & Chief Medical Officer	SSale	−1,200 sh	$52.20	−$62.6K	92,777
2021-12-15	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−5,000 sh	—	—	72,591

Recent filings

Accepted (ET)
Feb 264
Pang Phillip0001628280-24-006982
SEC(opens sec.gov)
Feb 164
Pang Phillip0001628280-24-005418
SEC(opens sec.gov)
Jan 34
Pang Phillip0001628280-24-000169
SEC(opens sec.gov)
Jun 84
Pang Phillip0001209191-23-035409
SEC(opens sec.gov)
Feb 284
Pang Phillip0001209191-23-013683
SEC(opens sec.gov)
Feb 244
Pang Phillip0001209191-23-012996
SEC(opens sec.gov)
Feb 214
Pang Phillip0001209191-23-011384
SEC(opens sec.gov)
Jan 254
Pang Phillip0001209191-23-004945
SEC(opens sec.gov)

Companies

Vir Biotechnology, Inc.EVP & Chief Medical OfficerVIR

Address

C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500

SAN FRANCISCO, CA, 94158